Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1988 May;62(5):1647–1652. doi: 10.1128/jvi.62.5.1647-1652.1988

A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses.

K H Hsu 1, K Lonberg-Holm 1, B Alstein 1, R L Crowell 1
PMCID: PMC253193  PMID: 2451756

Abstract

A 50-kilodalton receptor protein (Rp-a) for the group B coxsackieviruses (CB) was isolated in a virus-receptor complex from detergent-solubilized HeLa cells (J. E. Mapoles, D. L. Krah, and R. L. Crowell, J. Virol. 55:560-566, 1985). It was used as an immunogen for preparation of a mouse monoclonal antibody (RmcB) which protected HeLa cells and Buffalo green monkey kidney cells from infection by all six serotypes of CB. RmcB did not protect HeLa cells from infection by poliovirus, echovirus 6, or coxsackievirus A18. This monoclonal antibody differed in receptor epitope specificity from a previously isolated antibody (RmcA) (R. L. Crowell, A. K. Field, W. A. Schleif, W. L. Long, R. J. Colonno, J. E. Mapoles, and E. A. Emini, J. Virol. 57:438-445, 1986) which blocked receptors only for type 1 CB (CB1), CB3, CB5, and echovirus 6. RmcA and RmcB recognized two distinct saturable receptors on HeLa cells, designated HR2 and HR1, respectively. Human rhabdomyosarcoma (RD) cells have the HR2 receptor for CB3-RD (a variant of CB3), but lack the HR1 receptor for CB3. Therefore, RD cells were resistant to infection by CB3. Although binding of CB3-RD to the HR2 receptor on RD cells can lead to infection, binding of CB3-RD to the HR2 receptor on HeLa cells did not lead to infection. Apparently, both CB3 and CB3-RD use only the HR1 receptor for infection of HeLa cells. Thus, a given virus may use two distinct receptors to bind to cells when only one virus-receptor interaction leads to infection.

Full text

PDF
1647

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CROWELL R. L. SPECIFIC VIRAL INTERFERENCE IN HELA CELL CULTURES CHRONICALLY INFECTED WITH COXSACKIE B5 VIRUS. J Bacteriol. 1963 Sep;86:517–526. doi: 10.1128/jb.86.3.517-526.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. CROWELL R. L., SYVERTON J. T. The mammalian cell-virus relationship. VI. Sustained infection of HeLa cells by Coxsackie B3 virus and effect on superinfection. J Exp Med. 1961 Feb 1;113:419–435. doi: 10.1084/jem.113.2.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. CROWELL R. L., SYVERTON J. T. The viral range in vitro of a malignant, human epithelial cell (strain HeLa, Gey). IV. The cytopathogenicity of C viruses. J Immunol. 1955 Feb;74(2):169–177. [PubMed] [Google Scholar]
  4. Crowell R. L., Field A. K., Schleif W. A., Long W. L., Colonno R. J., Mapoles J. E., Emini E. A. Monoclonal antibody that inhibits infection of HeLa and rhabdomyosarcoma cells by selected enteroviruses through receptor blockade. J Virol. 1986 Feb;57(2):438–445. doi: 10.1128/jvi.57.2.438-445.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Crowell R. L., Philipson L. Specific alterations of coxsackievirus B3 eluted from HeLa cells. J Virol. 1971 Oct;8(4):509–515. doi: 10.1128/jvi.8.4.509-515.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Crowell R. L. Specific cell-surface alteration by enteroviruses as reflected by viral-attachment interference. J Bacteriol. 1966 Jan;91(1):198–204. doi: 10.1128/jb.91.1.198-204.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hughes J. V., Stanton L. W., Tomassini J. E., Long W. J., Scolnick E. M. Neutralizing monoclonal antibodies to hepatitis A virus: partial localization of a neutralizing antigenic site. J Virol. 1984 Nov;52(2):465–473. doi: 10.1128/jvi.52.2.465-473.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lonberg-Holm K., Crowell R. L., Philipson L. Unrelated animal viruses share receptors. Nature. 1976 Feb 26;259(5545):679–681. doi: 10.1038/259679a0. [DOI] [PubMed] [Google Scholar]
  9. Lonberg-Holm K., Philipson L. Early interaction between animal viruses and cells. Monogr Virol. 1974;9:1–148. [PubMed] [Google Scholar]
  10. Mapoles J. E., Krah D. L., Crowell R. L. Purification of a HeLa cell receptor protein for group B coxsackieviruses. J Virol. 1985 Sep;55(3):560–566. doi: 10.1128/jvi.55.3.560-566.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Menegus M. A., Hollick G. E. Increased Efficiency of Group B Coxsackievirus Isolation from Clinical Specimens by Use of BGM Cells. J Clin Microbiol. 1982 May;15(5):945–948. doi: 10.1128/jcm.15.5.945-948.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Reagan K. J., Goldberg B., Crowell R. L. Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells. J Virol. 1984 Mar;49(3):635–640. doi: 10.1128/jvi.49.3.635-640.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Schultz M., Crowell R. L. Eclipse of coxsackievirus infectivity: the restrictive event for a non-fusing myogenic cell line. J Gen Virol. 1983 Aug;64(Pt 8):1725–1734. doi: 10.1099/0022-1317-64-8-1725. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES